Clinical Trial

Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI)

Study acronym: SAITO 1B
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 3, 2025 (before its estimated November 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The TAVIPILOT Software by Caranx Medical is an advanced intraoperative assistance tool designed to enhance the accuracy of transcatheter aortic valve positioning during TAVI. It works alongside conventional fluoroscopy, using real-time image analysis to provide precise anatomical landmarks. TAVIPILOT Software detects key anatomical structures, tracks valve positioning, and uses AI-based confidence indicators to assist in alignment. The software is compatible with approved C-arm imaging systems and specific catheter models. The objective is to assess the feasibility and safety of the TAVIPILOT Software augmented reality guidance software during TAVI procedures, aiming to improve valve positioning precision and, implicitly and to reduce implantation depth variations.
Trial Details
NCT Number NCT07100340
Lead Sponsor Caranx Medical
Conditions TAVI(Transcatheter Aortic Valve Implantation)
Enrollment 10 participants
Start Date 2025-09-15
Primary Completion 2025-11-15 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-03